Capital Power declares dividends for its Common and Preference shares

The Board of Directors for Capital Power Corporation (“Capital Power”) (TSX: CPX) declared a dividend of $0.6910 per share on the outstanding common shares for the quarter ending March 31, 2026. The ...
ascopubs.org

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid ...

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials This phase III, open-label study ...
Medscape

CPX-351: Better Outcomes in Older High-Risk AML Patients

SAN DIEGO, California — A novel liposomal formulation of cytarabine and daunorubicin, known as CPX-351 (Vyxeos, Jazz Pharmaceuticals), has again been shown to be superior to a standard version of this ...
The American Journal of Managed Care

CPX-351 Effective in AML, Possibly With Reduced Cardiotoxicity vs Standard Anthracyclines

Liposomal daunorubicin and cytarabine (CPX-351) was effective in relapsed acute myeloid leukemia, but long-term follow-up is needed to determine the extent of the agent's cardiotoxicity. In a study of ...
adexchanger

CPX Interactive CEO Seiman Sees Strength In Consumer Goods and DM Clients With Upfront Revenues

Mike Seiman is CEO and Founder of global online ad network, CPX Interactive. AdExchanger.com: How’s CPX Interactive‘s display ad business? Any trends that you can share? MS: Our display business is ...